Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Share News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.90
Bid: 29.10
Ask: 30.70
Change: 0.10 (0.34%)
Spread: 1.60 (5.498%)
Open: 29.80
High: 0.00
Low: 0.00
Prev. Close: 29.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Concepta Unveils Genomic Covid-19 Test And Plans Name Change

Wed, 02nd Dec 2020 09:55

(Alliance News) - Concepta PLC on Wednesday said it has launched a Covid-19 genomic testing kit, and the myLotus pregnancy test maker also outlined plans for a name change.

Shares in Concepta jumped 32% to 2.12 pence each in London on Wednesday morning.

The healthcare company and fertility tracking firm launched a DNA testing service under the MyHealthChecked brand, in the wake of Concepta's acquisition of Genome Store Ltd, announced in November.

Concepta parted with an initial GBP280,000 to buy the home-use genetic testing company, plus a deferred consideration of up to GBP240,000.

The company said the test will be a "COVID-19 lab-based PCR test".

"The MyHealthChecked Covid-19 testing service will use the Clarigene SARS-CoV-2 test supplied by Yourgene Health PLC and the PrimeStore MTM sample collection device supplied by EKF Diagnostic Holdings PLC," Concepta added.

"The MyHealthChecked testing service allows samples to be quickly and conveniently taken at home using simple nasal collection swabs which are then sent via free postage for processing using established laboratory-based DNA and RNA detection methods."

Looking ahead, Concepta said it plans to launch a "number of DNA tests", in fields such as male and female wellness and food intolerance.

"Our priority is to look beyond the pandemic with a range of affordable, meaningful at-home test kits, but it would be remiss of us - now with the expertise and operational channel in-house - not to make this kit available to the public," Concepta Chief Executive Officer Penny McCormick said.

The company added that the "requirement for at home testing kits is expected to continue", despite promising news on the vaccine front.

The UK government on Wednesday said it has authorised Pfizer Inc and BioNTech SE's Covid-19 vaccine, becoming the first country in the world to give the jab the green light.

In changes that will take effect in "due course" Concepta said its name will change to MyHealthChecked PLC.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
27 Apr 2020 13:51

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

UK TRADING UPDATE SUMMARY: Novacyt Called Upon To Ramp Up UK Testing

Read more
24 Mar 2020 17:58

EKF Diagnostics Still Planning First Payout With Trading Going Well

EKF Diagnostics Still Planning First Payout With Trading Going Well

Read more
29 Jan 2020 12:39

EKF Diagnostic Expects Annual Results In Line With Expectations

EKF Diagnostic Expects Annual Results In Line With Expectations

Read more
6 Nov 2019 18:01

EKF Diagnostics Proposes Performance Bonuses Amid In-Line Trading

EKF Diagnostics Proposes Performance Bonuses Amid In-Line Trading

Read more
10 Sep 2019 11:17

EKF Interim Earnings Beat Internal Views; Inks Pact With Mount Sinai

(Alliance News) - EKF Diagnostics Holdings PLC on Tuesday said interim earnings were ahead of management expectations and its second half outlook remains encouraging."Revenues are to a

Read more
3 Sep 2019 16:17

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 4 September Oxford BiomedicaHalf Year ResultsDunelm GroupFull Year Year Income

Read more
15 Jul 2019 12:57

EKF Diagnostics Starts Year Well With Sales In Line With Forecasts

(Alliance News) - EKF Diagnostics Holdings PLC said Monday its current financial year has started "well" with sales in line with market forecasts.The point-of-care medial device a

Read more
28 May 2019 14:26

DIRECTOR DEALINGS: EKF Diagnostics Non-Exec Sells Shares, Chair Buys

LONDON (Alliance News) - Laboratory products firm EKF Diagnostics Holdings PLC on Tuesday said Non-Executive Director Adam Reynolds has sold shares worth over GBP100,000.In a transaction at

Read more
18 Mar 2019 12:56

Sureserve Group Appoints Harwood Founder As Non-Executive Director

LONDON (Alliance News) - Energy support services firm Sureserve Group PLC on Monday said it appointed Christopher Mills as a non-executive director of the company with immediate founded Harwood in

Read more
13 Mar 2019 15:06

EKF Diagnostics shares slide as firm reports middling progress

(Sharecast News) - Point-of-care business EKF Diagnostics Holdings reported a 2% improvement in its full-year revenue on Wednesday, to £42.5m.

Read more
13 Mar 2019 12:35

EKF Diagnostics 2018 Profit Jumps On Lower Costs, Higher Revenue

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Wednesday said its profit grew significantly in 2018 following a rise in revenue and a decrease in expenses.The AIM-listed medical a

Read more
22 Jan 2019 13:29

EKF Diagnostics blood analyser to begin US sales

(Sharecast News) - Point-of-care business EKF Diagnostics Holdings announced on Tuesday that, further to its private label distribution agreement with McKesson Medical-Surgical, sales of the McKesson Consult Hb analyser were expected next month, following the full launch of the product in the United States.

Read more
16 Jan 2019 10:16

EKF Diagnostics Expects Earnings "Comfortably" Ahead Of Market Views

LONDON (Alliance News) - EKF Diagnostics Holdings PLC on Wednesday said it expects its annual earnings to be "comfortably ahead of market expectations".For 2018, the point-of-care

Read more
6 Nov 2018 12:49

Renalytix AI Raises GBP22.3 Million, Begins Trading On AIM (ALLIPO)

LONDON (Alliance News) - Renalytix AI PLC started trading on London's AIM Tuesday after raising GBP22.3 million though a placing and subscription to EKF Diagnostics Holdings PLC developer of a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.